Mundipharma: Mundipharma, Vectura collaborate to reformulate asthma inhaler to reduce carbon footprint

They aim to achieve a near-zero-emissions asthma inhaler with a significantly lower impact on global warming Global healthcare company Mundipharma and Vectura, an inhalation contract development and manufacturing organization, have entered into a collaboration agreement aimed at reformulating an asthma inhaler as part of their commitment to reducing the product's carbon footprint. The companies will [...]The post Mundipharma, Vectura collaborate to reformulate asthma inhaler to reduce carbon footprint appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.